M&A Deal Summary |
|
|---|---|
| Date | 2016-08-22 |
| Target | Tiger X Medical |
| Sector | Medical Products |
| Buyer(s) | BioCardia |
| Deal Type | Merger |
SEARCH BY
BioCardia, Inc. is a privately-held company developing regenerative biologic therapies to treat cardiovascular disease. The Company's current products include the Helix™ transendocardial delivery system and the Morph® steerable guide and sheath catheter portfolio.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 1 |